CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project focuses on developing a biodegradable nanofibrous patch for localized drug delivery in lung cancer treatment. By utilizing nanotechnology and electrospinning techniques, it aims to create effective implantable devices that minimize cancer recurrence at surgical margins, enhancing patient outcomes.
Pulmonary cancer is the leading cause of cancer deaths worldwide.
Surgery is associated with high morbidity and operative mortality.
One of the main causes of the poor survival rate is cancer relapse at the surgical resection margins.
Thus, developing a strategy to minimize the local recurrence rate of lung cancer efficiently is greatly needed.
Nanotechnology-assisted approaches, such as nanoparticles (NPs) and nanofibers (NFs) obtained via electrospinning could enable novel strategies to fabric…
UNIVERSITA DI PISA
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
United States, Cambridge
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Italy, Pisa
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
The University of Texas Rio Grande Valley
United States, Edinburg
Type: Public body
Activity type: Public bodies (excluding Research Organisations and Secondary or Higher Education Establishments)
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
